Halozyme Therapeutics shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.4M | 114k | 73.34 |
| 2025-06-30 | $7.3M | 141k | 52.02 |
| 2025-03-31 | $9.2M | 144k | 63.81 |
| 2024-12-31 | $5.7M | 119k | 47.81 |
| 2024-09-30 | $7.0M | 122k | 57.24 |
| 2024-06-30 | $3.4M | 65k | 52.37 |
| 2024-03-31 | $2.2M | 53k | 40.69 |
| 2023-12-31 | $1.4M | 38k | 36.95 |
| 2023-09-30 | $1.7M | 45k | 38.20 |
| 2023-06-30 | $1.6M | 43k | 36.07 |
| 2023-03-31 | $1.1M | 29k | 38.20 |
| 2022-12-31 | $2.9M | 51k | 56.90 |
| 2022-09-30 | $1.7M | 43k | 39.55 |
| 2022-06-30 | $1.7M | 38k | 44.00 |
| 2022-03-31 | $1.2M | 30k | 39.88 |
| 2021-12-31 | $1.1M | 26k | 40.20 |
| 2021-09-30 | $1.2M | 30k | 40.68 |
| 2021-06-30 | $1.5M | 34k | 45.41 |
| 2021-03-31 | $1.3M | 32k | 41.67 |
| 2020-12-31 | $999k | 23k | 42.71 |
| 2020-09-30 | $1.4M | 52k | 26.28 |
| 2020-06-30 | $1.4M | 52k | 26.81 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors